Sponsor study identifier
interventional
60
1 country
1
Study Start
August 22, 2019
Actual (reported)Primary Completion
August 31, 2025
Actual (reported)Study Completion
August 31, 2025
Actual (reported)This single-arm, open-label study evaluates short-term symptom improvement and tolerability of continuous theta-burst stimulation (cTBS), a non-invasive brain stimulation technique, in adults with obsessive-compulsive disorder seeking a non-drug treatment option. Participants receive cTBS for 15 consecutive days. Symptoms are assessed before treatment and 1-2 days after the treatment course.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
August 31, 2025
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
August 22, 2019
Actual (reported)August 31, 2025
Actual (reported)August 31, 2025
Actual (reported)October 17, 2026
Actual (reported)October 27, 2026
Actual (reported)Symptom improvement assessed by the Yale-Brown Obsessive Compulsive Scale
The Yale-Brown Obsessive Compulsive Scale is a test to rate the severity of obsessive-compulsive disorder symptoms, which measures obsessions separately from compulsions. The scale includes 10 items, the first 5 items are evaluated obsessions, the rest are assessments compulsions. Each item 0-4 points, a total of 40 points. The lower the score, the better the outcome.
pre-treatment; 1-2 days post-treatment
Continuous theta-burst stimulation (cTBS) is delivered to the individually localized right pre-supplementary motor area (pre-SMA) using a Magstim Rapid2 stimulator with a 70-mm figure-of-eight coil. The target is selected based on pretreatment resting-state fMRI connectivity with the right subthalamic nucleus, and coil placement is guided by neuronavigation. Stimulation consists of three-pulse bursts at 50 Hz repeated at 5 Hz, at 80% of the resting motor threshold. Three sessions of 600 pulses each are delivered daily at 15-minute intersession intervals, totaling 1,800 pulses per day, for 15 consecutive days.
Anhui Medical University
Hefei, Anhui, 230032, China
60 participants (actual enrollment reported by the registry).
First Submitted
October 17, 2026
First Posted
October 27, 2026
Study Start
August 22, 2019
Actual (reported)Examining the Efficacy of Orbitofrontal Cortex rTMS for Depression
Contact the study team to confirm eligibility.
Primary Completion
August 31, 2025
Actual (reported)Study Completion
August 31, 2025
Actual (reported)Last Updated
October 27, 2026
Record last verified: 2026-10
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: